SEC Form 4 · accession 0001287920-26-000006
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gail Boudreaux
Officer — President and CEO · Director
Period of report
Jul 17, 2026
Accepted (ET)
Jul 17, 2026 · 1:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 17, 2026 | P | 680 | $366.41 | A | 169,931 | D | |
| Common StockF2 | Jul 17, 2026 | P | 2,045 | $368.25 | A | 171,976 | D | |
| Common Stock | holding | — | — | — | 60 | I | Shares Held in Spouse's Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.